Tom Curran, PhD

St. Jude Children's
Research Hospital

Use of a novel SHH pathway inhibitor in human medulloblastoma

Russell Matthews, PhD

Yale University

Targeting a glioma-specific isoform of BEHAB/brevican for glioma therapy

William Pardridge, MD

University of California
Los Angeles

Non-viral polygenic gene therapy of brain cancer

Paul Mischel, MD

University of California
Los Angeles

Molecular analysis of glioblastoma for kinase inhibitor therapy

John Reed, MD, PhD

The Burnham Institute

IAP antagonists for glioblastoma

Jeremy Rich, MD

Duke University

Targeting non-mitogenic receptor kinases and intracellular mediators in glioma therapy

Rosalind Segal, MD, PhD

Dana-Farber Cancer
Institute

Therapeutic use of CXCR4 antagonists in glioblastoma

Paul Workman, PhD

Institute of Cancer Research UK

Mechanism of action of novel phosphatidylinositol 3-kinase inhibitors for use in glioblastoma therapy

Margaret Wrensch, PhD

University of California
San Francisco

Evaluation of SNPs from whole genome scans in relation to glioma prognosis